# Anaptysbio, Inc: Form 10-K/A for the period ended Dec 31, 2025

- Company: [Anaptysbio, Inc](/companies/anab.md) (CIK 1370053)
- Form: 10-K/A
- Filed: 2026-04-28
- Accepted by EDGAR: Apr 28, 2026, 20:10 ET
- Period: 2025-12-31
- Accession: 0001193125-26-187044
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1370053/000119312526187044/anab-20251231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1370053/000119312526187044/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Net income | 12 months, 2025-01-01 to 2025-12-31 | −$13.2m | us-gaap:NetIncomeLoss |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1370053/000119312526187044/anab-20251231.htm

Filed Apr 28, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-187044. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.